Cargando…
Nrf2 Activation Sensitizes K-Ras Mutant Pancreatic Cancer Cells to Glutaminase Inhibition
Pancreatic cancer remains intractable owing to the lack of effective therapy for unresectable cases. Activating mutations of K-ras are frequently found in pancreatic cancers, but these have not yet been targeted by cancer therapies. The Keap1-Nrf2 system plays a crucial role in mediating the oxidati...
Autores principales: | Hamada, Shin, Matsumoto, Ryotaro, Tanaka, Yu, Taguchi, Keiko, Yamamoto, Masayuki, Masamune, Atsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918355/ https://www.ncbi.nlm.nih.gov/pubmed/33672789 http://dx.doi.org/10.3390/ijms22041870 |
Ejemplares similares
-
HIF-1 and NRF2; Key Molecules for Malignant Phenotypes of Pancreatic Cancer
por: Hamada, Shin, et al.
Publicado: (2022) -
Pancreatic Stellate Cells and Metabolic Alteration: Physiology and Pathophysiology
por: Hamada, Shin, et al.
Publicado: (2022) -
Senescent Human Pancreatic Stellate Cells Secrete CXCR2 Agonist CXCLs to Promote Proliferation and Migration of Human Pancreatic Cancer AsPC-1 and MIAPaCa-2 Cell Lines
por: Takikawa, Tetsuya, et al.
Publicado: (2022) -
The KEAP1–NRF2 System in Cancer
por: Taguchi, Keiko, et al.
Publicado: (2017) -
The KEAP1–NRF2 System as a Molecular Target of Cancer Treatment
por: Taguchi, Keiko, et al.
Publicado: (2020)